A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette des...
Saved in:
Published in | JNCI : Journal of the National Cancer Institute Vol. 101; no. 22; pp. 1553 - 1561 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cary, NC
Oxford University Press
18.11.2009
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8874 1460-2105 1460-2105 |
DOI | 10.1093/jnci/djp361 |
Cover
Loading…
Abstract | Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case–control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case–control studies conducted in New Hampshire in 1994–1998 and in 1998–2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994–1998, 1998–2001, and 2002–2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. |
---|---|
AbstractList | Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear.BACKGROUNDCigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear.We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects).METHODSWe examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects).Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity.RESULTSRegular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity.Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.CONCLUSIONSSmoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Here, Baris et al examine bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004. Their study results indicate that smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on their modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects). Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case–control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case–control studies conducted in New Hampshire in 1994–1998 and in 1998–2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994–1998, 1998–2001, and 2002–2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked. |
Author | Fraumeni, Joseph F. Johnson, Alison Waddell, Richard Schned, Alan Kelsey, Karl T. Silverman, Debra T. Cherala, Sai Verrill, Castine Schwenn, Molly Andrew, Angeline S. Lubin, Jay Colt, Joanne S. Samanic, Claudine Baris, Dalsu Rothman, Nathaniel Hoover, Robert N. Karagas, Margaret R. Marsit, Carmen J. Cantor, Kenneth P. |
AuthorAffiliation | Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) |
AuthorAffiliation_xml | – name: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) |
Author_xml | – sequence: 1 givenname: Dalsu surname: Baris fullname: Baris, Dalsu email: barisd@mail.nih.gov organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 2 givenname: Margaret R. surname: Karagas fullname: Karagas, Margaret R. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 3 givenname: Castine surname: Verrill fullname: Verrill, Castine organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 4 givenname: Alison surname: Johnson fullname: Johnson, Alison organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 5 givenname: Angeline S. surname: Andrew fullname: Andrew, Angeline S. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 6 givenname: Carmen J. surname: Marsit fullname: Marsit, Carmen J. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 7 givenname: Molly surname: Schwenn fullname: Schwenn, Molly organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 8 givenname: Joanne S. surname: Colt fullname: Colt, Joanne S. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 9 givenname: Sai surname: Cherala fullname: Cherala, Sai organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 10 givenname: Claudine surname: Samanic fullname: Samanic, Claudine organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 11 givenname: Richard surname: Waddell fullname: Waddell, Richard organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 12 givenname: Kenneth P. surname: Cantor fullname: Cantor, Kenneth P. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 13 givenname: Alan surname: Schned fullname: Schned, Alan organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 14 givenname: Nathaniel surname: Rothman fullname: Rothman, Nathaniel organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 15 givenname: Jay surname: Lubin fullname: Lubin, Jay organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 16 givenname: Joseph F. surname: Fraumeni fullname: Fraumeni, Joseph F. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 17 givenname: Robert N. surname: Hoover fullname: Hoover, Robert N. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 18 givenname: Karl T. surname: Kelsey fullname: Kelsey, Karl T. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) – sequence: 19 givenname: Debra T. surname: Silverman fullname: Silverman, Debra T. organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ) |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22174367$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19917915$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFu1DAQhi1URLctJ-4oQgIOVVrbceyEA1JZtRRUqYUtqOrF8trO4t3EXmynojfegTfkSfAqywKVUOcyh_nm169_ZgdsWWc1AE8QPECwLg7nVppDNV8WFD0AI0QozDGC5RYYQYhZXlWMbIOdEOYwVY3JI7CN6hqxGpUj8PkoG4ugf37_MXY2etdmk9ir28w12aRzC2NnmbAqe9MKpbRPrJWpfTRh8So77rSfaRuzCxGj9jZk5zdpeGk6vQceNqIN-vG674JPJ8eX49P87Pztu_HRWS5LymJeIUkLopkoKlJQxWgjp7qEmrK6rgjEihAJGSpJoWBJsERCUooaMiVSKqXKYhe8HnSX_bTTSiY3XrR86U0n_C13wvB_J9Z84TN3wzFjFWUoCbxcC3j3tdch8s4EqdtWWO36wKuUVAERw_eSrCCIlFUNE_nsDjl3vbcpB44xrCuG6cr507-dbyz_Pk0Cnq8BEaRoG5-iN2HDYYxYyowlbn_gpHcheN38kYJ89SB89SB8eJBEozu0NFFEszq-MO1_dl4MO65f3iOeD6AJUX_boMIveDLKSn56dc0n9D27uL76kAL7BazT21w |
CODEN | JNCIEQ |
CitedBy_id | crossref_primary_10_1016_j_tox_2019_152325 crossref_primary_10_1097_EDE_0000000000000964 crossref_primary_10_1093_carcin_bgq223 crossref_primary_10_1289_EHP9895 crossref_primary_10_1158_1055_9965_EPI_20_1045 crossref_primary_10_1002_cncr_28397 crossref_primary_10_1016_j_canep_2022_102233 crossref_primary_10_1590_s1677_5538_ibju_2018_0068 crossref_primary_10_16899_jcm_758091 crossref_primary_10_1016_j_hoc_2021_02_001 crossref_primary_10_1097_MOU_0b013e32833dde0d crossref_primary_10_1016_j_urology_2020_12_033 crossref_primary_10_4132_KoreanJPathol_2011_45_1_62 crossref_primary_10_1016_j_afju_2018_11_008 crossref_primary_10_1016_j_ebiom_2018_10_051 crossref_primary_10_1002_ijc_26245 crossref_primary_10_1016_j_tox_2018_02_008 crossref_primary_10_1016_j_urology_2015_12_032 crossref_primary_10_1007_s13277_015_4566_9 crossref_primary_10_1111_j_1742_1241_2011_02763_x crossref_primary_10_1080_17512433_2023_2219446 crossref_primary_10_2217_epi_2023_0358 crossref_primary_10_1260_2040_2295_3_4_535 crossref_primary_10_1016_j_jprot_2013_04_024 crossref_primary_10_1016_j_juro_2013_01_024 crossref_primary_10_3390_ijerph15040569 crossref_primary_10_1371_journal_pone_0091147 crossref_primary_10_1158_0008_5472_CAN_12_2388 crossref_primary_10_1053_j_ajkd_2011_01_017 crossref_primary_10_1016_j_acuroe_2013_02_008 crossref_primary_10_1016_j_clgc_2024_102296 crossref_primary_10_1111_j_1464_410X_2011_10371_x crossref_primary_10_4254_wjh_v7_i7_942 crossref_primary_10_1158_1078_0432_CCR_20_4419 crossref_primary_10_1016_j_tox_2021_152801 crossref_primary_10_1007_s00394_022_02932_w crossref_primary_10_1667_RR2841_1 crossref_primary_10_1111_ijun_12387 crossref_primary_10_1007_s11596_013_1218_4 crossref_primary_10_1111_ijcp_12143 crossref_primary_10_1002_ijc_28325 crossref_primary_10_1093_carcin_bgq178 crossref_primary_10_1097_CEJ_0000000000000404 crossref_primary_10_1007_s12561_023_09404_7 crossref_primary_10_1155_2012_101850 crossref_primary_10_1002_ijc_27590 crossref_primary_10_1158_1055_9965_EPI_10_0823 crossref_primary_10_1111_bju_15640 crossref_primary_10_1007_s10552_011_9792_x crossref_primary_10_1007_s11255_022_03173_w crossref_primary_10_1620_tjem_239_9 crossref_primary_10_1016_j_urology_2010_10_032 crossref_primary_10_1016_j_urology_2011_06_055 crossref_primary_10_1016_j_cancergencyto_2010_07_135 crossref_primary_10_1007_s10552_011_9788_6 crossref_primary_10_5402_2012_283670 crossref_primary_10_1093_jnci_djw099 crossref_primary_10_1016_j_urolonc_2012_09_001 crossref_primary_10_1016_j_oraloncology_2019_05_006 crossref_primary_10_1007_s13300_015_0128_9 crossref_primary_10_4236_health_2011_310103 crossref_primary_10_1007_s10552_017_0885_z crossref_primary_10_1158_1055_9965_EPI_23_0331 crossref_primary_10_1016_j_urology_2011_08_072 crossref_primary_10_1002_ajim_22328 crossref_primary_10_1016_j_acuro_2013_02_004 crossref_primary_10_1093_ije_dyv175 crossref_primary_10_1111_ijcp_12127 crossref_primary_10_1002_ijc_33486 crossref_primary_10_7314_APJCP_2013_14_8_4553 crossref_primary_10_1002_cncr_28915 crossref_primary_10_1007_s00420_016_1182_y crossref_primary_10_1007_s11356_013_1716_8 crossref_primary_10_2217_fon_12_180 crossref_primary_10_1016_j_eururo_2016_04_009 crossref_primary_10_1293_tox_2013_0039 crossref_primary_10_1016_j_toxlet_2020_11_005 crossref_primary_10_3389_fonc_2023_1126897 crossref_primary_10_1111_bju_12032 crossref_primary_10_3390_curroncol30020154 crossref_primary_10_1016_j_tox_2013_11_002 crossref_primary_10_1136_bmjopen_2011_000084 crossref_primary_10_1097_CCO_0b013e3283446a11 crossref_primary_10_3233_BLC_170111 crossref_primary_10_1093_jnci_djv223 crossref_primary_10_1158_1055_9965_EPI_11_1030 crossref_primary_10_1007_s00216_014_8080_5 crossref_primary_10_1038_s41370_024_00651_4 crossref_primary_10_1016_j_eururo_2011_03_027 crossref_primary_10_1371_journal_pone_0186214 crossref_primary_10_1186_s13148_022_01234_6 crossref_primary_10_1155_2013_986023 crossref_primary_10_1002_sim_9527 crossref_primary_10_1097_EDE_0000000000001112 crossref_primary_10_1200_JCO_2011_36_6518 crossref_primary_10_1097_MOU_0000000000000453 crossref_primary_10_1158_0008_5472_CAN_11_1154 crossref_primary_10_1093_ije_dyw044 crossref_primary_10_1007_s10147_011_0363_7 crossref_primary_10_1214_13_AOAS665 crossref_primary_10_1007_s10552_019_01161_7 crossref_primary_10_1007_s11934_014_0416_3 crossref_primary_10_1016_j_ijsu_2011_05_003 crossref_primary_10_1038_bjc_2012_187 crossref_primary_10_1158_1055_9965_EPI_12_0261 crossref_primary_10_1289_ehp_1002345 crossref_primary_10_1093_aje_kwu324 crossref_primary_10_1007_s00117_022_00992_x crossref_primary_10_1016_j_yrtph_2016_06_012 crossref_primary_10_1111_j_1464_410X_2010_09874_x crossref_primary_10_1177_0960327117734623 crossref_primary_10_1002_lt_22247 crossref_primary_10_1289_EHP89 crossref_primary_10_1007_s10552_014_0416_0 crossref_primary_10_1080_08958378_2018_1448019 crossref_primary_10_1158_1940_6207_CAPR_18_0441 crossref_primary_10_1371_journal_pone_0012334 crossref_primary_10_1093_carcin_bgu064 crossref_primary_10_1158_1055_9965_EPI_22_0801 crossref_primary_10_1016_S0084_4071_10_79512_9 crossref_primary_10_1093_jnci_djp385 crossref_primary_10_1177_2051415820947239 crossref_primary_10_1111_ijcp_12075 |
Cites_doi | 10.1021/ac60273a017 10.1093/jat/30.3.187 10.1097/EDE.0b013e31812717fe 10.1023/A:1013954932343 10.1158/1055-9965.EPI-05-0863 10.1093/acprof:oso/9780195149616.003.0058 10.1093/aje/kwk047 10.1158/1055-9965.EPI-06-0021 10.1093/ije/dym043 10.1111/j.1464-410X.1994.tb07120.x 10.1093/aje/kwm392 10.1006/pmed.1997.0183 10.1002/ijc.11020 10.1056/NEJM199905063401810 10.1021/tx980005y 10.1023/A:1018453104303 10.1002/ijc.21183 10.1038/bjc.1985.106 10.1002/ijc.2910440411 10.1158/0008-5472.CAN-07-0048 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M 10.1093/jnci/93.7.538 10.1002/(SICI)1097-0142(19970801)80:3<382::AID-CNCR5>3.0.CO;2-U 10.1002/rcm.1161 10.1023/B:CACO.0000036452.55199.a3 10.1007/s10552-006-0068-9 10.1158/1055-9965.EPI-04-0468 10.1093/acprof:oso/9780199566655.003.0006 10.1002/1097-0142(19860115)57:2<362::AID-CNCR2820570229>3.0.CO;2-F 10.1002/ijc.22169 10.1021/tx000260u 10.1038/bjc.1997.287 10.1093/aje/kwm089 10.1158/1055-9965.EPI-08-0613 10.1007/s00345-003-0382-8 10.1007/s002130051027 10.1093/jnci/90.19.1486 10.1093/jat/3.4.150 |
ContentType | Journal Article |
Copyright | Published by Oxford University Press 2009. 2009 2015 INIST-CNRS Copyright Oxford Publishing Limited(England) Nov 18, 2009 |
Copyright_xml | – notice: Published by Oxford University Press 2009. 2009 – notice: 2015 INIST-CNRS – notice: Copyright Oxford Publishing Limited(England) Nov 18, 2009 |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TO 7U7 7U9 C1K H94 K9. NAPCQ 7X8 7U1 5PM |
DOI | 10.1093/jnci/djp361 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Risk Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Environmental Sciences and Pollution Management MEDLINE - Academic Risk Abstracts |
DatabaseTitleList | MEDLINE - Academic Nursing & Allied Health Premium MEDLINE Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2105 |
EndPage | 1561 |
ExternalDocumentID | PMC2778671 1914779611 19917915 22174367 10_1093_jnci_djp361 10.1093/jnci/djp361 ark_67375_HXZ_S6J7PZXQ_7 |
Genre | Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural Feature |
GeographicLocations | United States North America America Vermont Maine New Hampshire USA, Maine USA, New Hampshire USA, Vermont |
GeographicLocations_xml | – name: Vermont – name: New Hampshire – name: Maine – name: USA, New Hampshire – name: USA, Maine – name: USA, Vermont |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA57494 – fundername: NCI NIH HHS grantid: R01 CA057494 – fundername: NCI NIH HHS grantid: R01 CA121147 – fundername: Intramural NIH HHS – fundername: NCI NIH HHS grantid: CA121147 – fundername: NIEHS NIH HHS grantid: P42 ES007373 |
GroupedDBID | --- -DD -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 186 1TH 29L 2QL 2WC 354 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WD 70D 8WZ 96U A6W AABZA AACZT AAGKA AAHTB AAJKP AAJQQ AAKAS AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL ABCQX ABDFA ABEFU ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPEJ ABPMR ABPPZ ABPTD ABQLI ABQNK ABSMQ ABVGC ABXVV ABZBJ ACBMB ACFRR ACGFO ACGFS ACGOD ACKOT ACNCT ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADXHL ADYVW ADZCM AEGPL AEHUL AEJOX AEKPW AEKSI AEMDU AEMQT AENZO AEPUE AETBJ AETEA AEWNT AFAZI AFCHL AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGNAY AGORE AGQPQ AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJBYB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BKOMP BSCLL BTRTY BVRKM BZKNY C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS EE~ EIHJH EJD EMOBN ENERS F5P F8P F9B FA8 FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GOZPB GRPMH GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LXL LXN LXY M-Z MBLQV MHKGH ML0 MVM N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ OAUYM OAWHX OBFPC OBH OCB OCZFY ODMLO ODZKP OGEVE OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q.- Q1. Q5Y QBD R44 RD5 RNI RNS ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TMA TR2 TWZ UDS UPT VH1 VVN W8F WH7 WOQ X7H X7M XJT Y6R YAYTL YHZ YKOAZ YQT YR5 YXANX ZKX ZRR ZY1 ~91 ~H1 ~X8 AASNB ABQTQ ADJQC ADRIX ADZXQ M49 RHF AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM VXZ 7TO 7U7 7U9 C1K H94 K9. NAPCQ 7X8 7U1 5PM |
ID | FETCH-LOGICAL-c567t-81c634e7a38436d76fcbe50e67998402d44c071543d0542c1ac661f4b4ccddd53 |
ISSN | 0027-8874 1460-2105 |
IngestDate | Thu Aug 21 18:18:38 EDT 2025 Fri Jul 11 04:57:13 EDT 2025 Fri Jul 11 08:35:12 EDT 2025 Mon Jun 30 10:51:06 EDT 2025 Wed Feb 19 01:47:24 EST 2025 Mon Jul 21 09:16:21 EDT 2025 Thu Apr 24 23:09:31 EDT 2025 Tue Jul 01 01:42:08 EDT 2025 Wed Sep 11 04:51:28 EDT 2024 Tue Aug 05 16:47:46 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Keywords | Human Urinary system disease Tobacco smoking Urinary tract disease Malignant tumor Case control study Bladder cancer Epidemiology Urology Cancerology Risk factor Bladder disease Public health Cancer |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c567t-81c634e7a38436d76fcbe50e67998402d44c071543d0542c1ac661f4b4ccddd53 |
Notes | istex:42D610D81F29699A23EFDBEA3D41DACB7DE02861 ark:/67375/HXZ-S6J7PZXQ-7 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
PMID | 19917915 |
PQID | 220987265 |
PQPubID | 41605 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2778671 proquest_miscellaneous_899130172 proquest_miscellaneous_734145890 proquest_journals_220987265 pubmed_primary_19917915 pascalfrancis_primary_22174367 crossref_primary_10_1093_jnci_djp361 crossref_citationtrail_10_1093_jnci_djp361 oup_primary_10_1093_jnci_djp361 istex_primary_ark_67375_HXZ_S6J7PZXQ_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-11-18 |
PublicationDateYYYYMMDD | 2009-11-18 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-18 day: 18 |
PublicationDecade | 2000 |
PublicationPlace | Cary, NC |
PublicationPlace_xml | – name: Cary, NC – name: United States – name: Oxford |
PublicationTitle | JNCI : Journal of the National Cancer Institute |
PublicationTitleAlternate | J Natl Cancer Inst |
PublicationYear | 2009 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | Lubin ( key 20170702081950_bib22) 2006; 15 Karagas ( key 20170702081950_bib23) 2004; 15 Wynder ( key 20170702081950_bib33) 1998; 90 Samanic ( key 20170702081950_bib8) 2006; 15 Fortuny ( key 20170702081950_bib24) 2007; 7 Jones ( key 20170702081950_bib2) 1999; 340 Burns ( key 20170702081950_bib35) Stellman ( key 20170702081950_bib34) 1997; 80 Sorahan ( key 20170702081950_bib12) 1994; 74 Alberg ( key 20170702081950_bib14) 2007; 165 Day ( key 20170702081950_bib43) 1980; 64 Vineis ( key 20170702081950_bib9) 2000; 463 Decarli ( key 20170702081950_bib36) 1985; 51 Lubin ( key 20170702081950_bib38) 2007; 36 Lubin ( key 20170702081950_bib42) 2007; 18 Brooks ( key 20170702081950_bib30) 2005; 14 Hoffmann ( key 20170702081950_bib20) 2001; 14 Lubin ( key 20170702081950_bib21) 2007; 166 Kabat ( key 20170702081950_bib17) 1986; 57 Jemal ( key 20170702081950_bib32) 2003; 105 Vineis ( key 20170702081950_bib40) 2001; 10 Brennan ( key 20170702081950_bib44) 2000; 86 Hartge ( key 20170702081950_bib10) 1987; 78 Zeegers ( key 20170702081950_bib16) 2002; 13 Scherer ( key 20170702081950_bib29) 1999; 145 Lubin ( key 20170702081950_bib37) 2008; 167 Sak ( key 20170702081950_bib39) 2007; 8 Law ( key 20170702081950_bib41) 1997; 75 Jiang ( key 20170702081950_bib13) 2007; 67 Benowitz ( key 20170702081950_bib28) Bjerregaard ( key 20170702081950_bib45) 2006; 119 Hecht ( key 20170702081950_bib5) 1998; 11 Masuda ( key 20170702081950_bib27) 1969; 41 Hoffmann ( key 20170702081950_bib18) Devesa ( key 20170702081950_bib31) 2005; 117 Vineis ( key 20170702081950_bib6) 1997; 8 Riedel ( key 20170702081950_bib4) 2006; 30 Hoffmann ( key 20170702081950_bib19) 1997; 26 Silverman ( key 20170702081950_bib1) 2006 Castelao ( key 20170702081950_bib11) 2001; 93 Burch ( key 20170702081950_bib47) 1989; 44 Bjerregaard ( key 20170702081950_bib15) 2006; 17 Patrianakos ( key 20170702081950_bib26) 1979; 3 Zeegers ( key 20170702081950_bib46) 2004; 21 Skipper ( key 20170702081950_bib7) 2003; 12 Peppone ( key 20170702081950_bib25) Van Hemelrijck ( key 20170702081950_bib48) 2009; 18 Stabbert ( key 20170702081950_bib3) 2003; 17 14685762 - World J Urol. 2004 Feb;21(6):392-401 5788023 - Anal Chem. 1969 Apr;41(4):650-2 2793235 - Int J Cancer. 1989 Oct 15;44(4):622-8 9245661 - Prev Med. 1997 Jul-Aug;26(4):427-34 9625726 - Chem Res Toxicol. 1998 Jun;11(6):559-603 15767332 - Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):576-81 18250081 - Am J Epidemiol. 2008 Apr 15;167(8):970-5 19917914 - J Natl Cancer Inst. 2009 Nov 18;101(22):1525-6 17700253 - Epidemiology. 2007 Sep;18(5):639-48 3942969 - Cancer. 1986 Jan 15;57(2):362-7 16894557 - Int J Cancer. 2006 Nov 15;119(10):2412-6 17510079 - Int J Epidemiol. 2007 Feb;36(1):236-41 3473252 - J Natl Cancer Inst. 1987 Jun;78(6):1119-25 19880815 - J Natl Cancer Inst. 2009 Nov 18;101(22):1532-4 17111263 - Cancer Causes Control. 2006 Dec;17(10):1305-9 16835335 - Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54 11751441 - Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52 9184188 - Br J Cancer. 1997;75(11):1690-3 6929006 - J Natl Cancer Inst. 1980 Apr;64(4):977-89 11287448 - J Natl Cancer Inst. 2001 Apr 4;93(7):538-45 12955743 - Rapid Commun Mass Spectrom. 2003;17(18):2125-32 9776415 - J Natl Cancer Inst. 1998 Oct 7;90(19):1486-8 10445368 - Psychopharmacology (Berl). 1999 Jul;145(1):1-20 10228196 - N Engl J Med. 1999 May 6;340(18):1424-6 15900604 - Int J Cancer. 2005 Nov 1;117(2):294-9 16803653 - J Anal Toxicol. 2006 Apr;30(3):187-95 17204516 - Am J Epidemiol. 2007 Mar 15;165(6):660-6 19336562 - Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1312-20 17425776 - BMC Genet. 2007;8:13 10738259 - Int J Cancer. 2000 Apr 15;86(2):289-94 10928863 - Mutat Res. 2000 Jul;463(1):103-10 7827847 - Br J Urol. 1994 Dec;74(6):753-6 16537710 - Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):517-23 17548786 - Am J Epidemiol. 2007 Aug 15;166(4):479-89 12814994 - Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7 12672038 - Int J Cancer. 2003 May 20;105(1):101-7 17692123 - BMC Urol. 2007;7:13 9241071 - Cancer. 1997 Aug 1;80(3):382-8 15286466 - Cancer Causes Control. 2004 Jun;15(5):465-72 9498898 - Cancer Causes Control. 1997 May;8(3):346-55 17671226 - Cancer Res. 2007 Aug 1;67(15):7540-5 11453723 - Chem Res Toxicol. 2001 Jul;14(7):767-90 3994914 - Br J Cancer. 1985 May;51(5):707-12 11899922 - Cancer Causes Control. 2002 Feb;13(1):83-90 |
References_xml | – volume: 41 start-page: 650 issue: 4 year: 1969 ident: key 20170702081950_bib27 article-title: Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke publication-title: Anal Chem. doi: 10.1021/ac60273a017 – volume: 30 start-page: 187 issue: 3 year: 2006 ident: key 20170702081950_bib4 article-title: Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers publication-title: J Anal Toxicol doi: 10.1093/jat/30.3.187 – volume: 18 start-page: 639 issue: 5 year: 2007 ident: key 20170702081950_bib42 article-title: Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity publication-title: Epidemiology doi: 10.1097/EDE.0b013e31812717fe – volume: 13 start-page: 83 issue: 1 year: 2002 ident: key 20170702081950_bib16 article-title: A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands) publication-title: Cancer Causes Control doi: 10.1023/A:1013954932343 – volume: 15 start-page: 517 issue: 3 year: 2006 ident: key 20170702081950_bib22 article-title: Cigarette smoking and lung cancer: modeling total exposure and intensity publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0863 – start-page: 1101 volume-title: Cancer Epidemiology and Prevention year: 2006 ident: key 20170702081950_bib1 article-title: Bladder cancer doi: 10.1093/acprof:oso/9780195149616.003.0058 – volume: 165 start-page: 660 issue: 6 year: 2007 ident: key 20170702081950_bib14 article-title: A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke publication-title: Am J Epidemiol doi: 10.1093/aje/kwk047 – volume: 15 start-page: 1348 issue: 7 year: 2006 ident: key 20170702081950_bib8 article-title: Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0021 – volume: 36 start-page: 236 issue: 1 year: 2007 ident: key 20170702081950_bib38 article-title: Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study publication-title: Int J Epidemiol doi: 10.1093/ije/dym043 – volume: 74 start-page: 753 issue: 6 year: 1994 ident: key 20170702081950_bib12 article-title: Urothelial cancer and cigarette smoking: findings from a regional case-controlled study publication-title: Br J Urol doi: 10.1111/j.1464-410X.1994.tb07120.x – volume: 167 start-page: 970 issue: 8 year: 2008 ident: key 20170702081950_bib37 article-title: Cigarette smoking and cancer: intensity patterns in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finnish men publication-title: Am J Epidemiol doi: 10.1093/aje/kwm392 – volume: 26 start-page: 427 issue: 4 year: 1997 ident: key 20170702081950_bib19 article-title: The changing cigarette publication-title: Prev Med doi: 10.1006/pmed.1997.0183 – volume: 105 start-page: 101 issue: 1 year: 2003 ident: key 20170702081950_bib32 article-title: Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type publication-title: Int J Cancer doi: 10.1002/ijc.11020 – volume: 340 start-page: 1424 issue: 18 year: 1999 ident: key 20170702081950_bib2 article-title: Prevention of bladder cancer publication-title: N Engl J Med doi: 10.1056/NEJM199905063401810 – volume: 8 issue: 13 year: 2007 ident: key 20170702081950_bib39 article-title: DNA repair gene XRCC1 polymorphisms and bladder cancer risk publication-title: BMC Genet. – volume: 11 start-page: 559 issue: 6 year: 1998 ident: key 20170702081950_bib5 article-title: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines publication-title: Chem Res Toxicol doi: 10.1021/tx980005y – volume: 8 start-page: 346 issue: 3 year: 1997 ident: key 20170702081950_bib6 article-title: Aromatic amines and cancer publication-title: Cancer Causes Control doi: 10.1023/A:1018453104303 – volume: 117 start-page: 294 issue: 2 year: 2005 ident: key 20170702081950_bib31 article-title: International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising publication-title: Int J Cancer doi: 10.1002/ijc.21183 – volume: 51 start-page: 707 issue: 5 year: 1985 ident: key 20170702081950_bib36 article-title: Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis publication-title: Br J Cancer doi: 10.1038/bjc.1985.106 – volume: 44 start-page: 622 issue: 4 year: 1989 ident: key 20170702081950_bib47 article-title: Risk of bladder cancer by source and type of tobacco exposure: a case-control study publication-title: Int J Cancer doi: 10.1002/ijc.2910440411 – ident: key 20170702081950_bib25 article-title: Cigarette smoking, bladder cancer and change in risk over 40 years publication-title: Frontiers in Cancer Prevention Research Conference Proceedings – volume: 67 start-page: 7540 issue: 15 year: 2007 ident: key 20170702081950_bib13 article-title: Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-0048 – volume: 86 start-page: 289 issue: 2 year: 2000 ident: key 20170702081950_bib44 article-title: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M – volume: 463 start-page: 103 issue: 1 year: 2000 ident: key 20170702081950_bib9 article-title: Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation publication-title: Mutat Res. – volume: 93 start-page: 538 issue: 7 year: 2001 ident: key 20170702081950_bib11 article-title: Gender- and smoking-related bladder cancer risk publication-title: J Natl Cancer Inst doi: 10.1093/jnci/93.7.538 – volume: 80 start-page: 382 issue: 3 year: 1997 ident: key 20170702081950_bib34 article-title: Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970801)80:3<382::AID-CNCR5>3.0.CO;2-U – volume: 17 start-page: 2125 issue: 18 year: 2003 ident: key 20170702081950_bib3 article-title: Analysis of aromatic amines in cigarette smoke publication-title: Rapid Commun Mass Spectrom doi: 10.1002/rcm.1161 – volume: 15 start-page: 465 issue: 5 year: 2004 ident: key 20170702081950_bib23 article-title: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire publication-title: Cancer Causes Control doi: 10.1023/B:CACO.0000036452.55199.a3 – volume: 17 start-page: 1305 issue: 10 year: 2006 ident: key 20170702081950_bib15 article-title: The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC) publication-title: Cancer Causes Control doi: 10.1007/s10552-006-0068-9 – volume: 14 start-page: 576 issue: 3 year: 2005 ident: key 20170702081950_bib30 article-title: Influence of type of cigarette on peripheral versus central lung cancer publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-04-0468 – volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine ident: key 20170702081950_bib18 article-title: The changing cigarettes: chemical studies and bioassays doi: 10.1093/acprof:oso/9780199566655.003.0006 – volume: 57 start-page: 362 issue: 2 year: 1986 ident: key 20170702081950_bib17 article-title: Bladder cancer in nonsmokers publication-title: Cancer doi: 10.1002/1097-0142(19860115)57:2<362::AID-CNCR2820570229>3.0.CO;2-F – volume: 119 start-page: 2412 issue: 10 year: 2006 ident: key 20170702081950_bib45 article-title: Tobacco smoke and bladder cancer–in the European Prospective Investigation into Cancer and Nutrition publication-title: Int J Cancer doi: 10.1002/ijc.22169 – volume: 10 start-page: 1249 issue: 12 year: 2001 ident: key 20170702081950_bib40 article-title: Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies publication-title: Cancer Epidemiol Biomarkers Prev – volume: 12 start-page: 503 issue: 6 year: 2003 ident: key 20170702081950_bib7 article-title: Nonsmoking-related arylamine exposure and bladder cancer risk publication-title: Cancer Epidemiol Biomarkers Prev – volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine ident: key 20170702081950_bib28 article-title: Compensatory smoking of low yields cigarettes – volume: 78 start-page: 1119 issue: 6 year: 1987 ident: key 20170702081950_bib10 article-title: Changing cigarette habits and bladder cancer risk: a case-control study publication-title: J Natl Cancer Inst – volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine ident: key 20170702081950_bib35 article-title: Smoking lower yield cigarettes and disease risk – volume: 14 start-page: 767 issue: 7 year: 2001 ident: key 20170702081950_bib20 article-title: The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder publication-title: Chem Res Toxicol doi: 10.1021/tx000260u – volume: 75 start-page: 1690 issue: 11 year: 1997 ident: key 20170702081950_bib41 article-title: The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer publication-title: Br J Cancer doi: 10.1038/bjc.1997.287 – volume: 166 start-page: 479 issue: 4 year: 2007 ident: key 20170702081950_bib21 article-title: Cigarette smoking and cancer risk: modeling total exposure and intensity publication-title: Am J Epidemiol doi: 10.1093/aje/kwm089 – volume: 64 start-page: 977 issue: 4 year: 1980 ident: key 20170702081950_bib43 article-title: Multistage models and primary prevention of cancer publication-title: J Natl Cancer Inst – volume: 18 start-page: 1312 issue: 4 year: 2009 ident: key 20170702081950_bib48 article-title: Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0613 – volume: 21 start-page: 392 issue: 6 year: 2004 ident: key 20170702081950_bib46 article-title: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review publication-title: World J Urol doi: 10.1007/s00345-003-0382-8 – volume: 145 start-page: 1 issue: 1 year: 1999 ident: key 20170702081950_bib29 article-title: Smoking behaviour and compensation: a review of the literature publication-title: Psychopharmacology ( Berl ) doi: 10.1007/s002130051027 – volume: 90 start-page: 1486 issue: 19 year: 1998 ident: key 20170702081950_bib33 article-title: Re: Cigarette smoking and the histopathology of lung cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/90.19.1486 – volume: 7 issue: 13 year: 2007 ident: key 20170702081950_bib24 article-title: Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study publication-title: BMC Urol – volume: 3 start-page: 150 issue: 4 year: 1979 ident: key 20170702081950_bib26 article-title: Chemical studies on tobacco smoke LXIV. On the analyses of aromatic amines in cigarettes smoke publication-title: J Anal Toxicol doi: 10.1093/jat/3.4.150 – reference: 15767332 - Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):576-81 – reference: 19336562 - Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1312-20 – reference: 17111263 - Cancer Causes Control. 2006 Dec;17(10):1305-9 – reference: 9625726 - Chem Res Toxicol. 1998 Jun;11(6):559-603 – reference: 18250081 - Am J Epidemiol. 2008 Apr 15;167(8):970-5 – reference: 17700253 - Epidemiology. 2007 Sep;18(5):639-48 – reference: 15286466 - Cancer Causes Control. 2004 Jun;15(5):465-72 – reference: 10445368 - Psychopharmacology (Berl). 1999 Jul;145(1):1-20 – reference: 11751441 - Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52 – reference: 9776415 - J Natl Cancer Inst. 1998 Oct 7;90(19):1486-8 – reference: 5788023 - Anal Chem. 1969 Apr;41(4):650-2 – reference: 9184188 - Br J Cancer. 1997;75(11):1690-3 – reference: 16894557 - Int J Cancer. 2006 Nov 15;119(10):2412-6 – reference: 17692123 - BMC Urol. 2007;7:13 – reference: 16537710 - Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):517-23 – reference: 3473252 - J Natl Cancer Inst. 1987 Jun;78(6):1119-25 – reference: 17548786 - Am J Epidemiol. 2007 Aug 15;166(4):479-89 – reference: 11899922 - Cancer Causes Control. 2002 Feb;13(1):83-90 – reference: 19917914 - J Natl Cancer Inst. 2009 Nov 18;101(22):1525-6 – reference: 12672038 - Int J Cancer. 2003 May 20;105(1):101-7 – reference: 17425776 - BMC Genet. 2007;8:13 – reference: 11453723 - Chem Res Toxicol. 2001 Jul;14(7):767-90 – reference: 15900604 - Int J Cancer. 2005 Nov 1;117(2):294-9 – reference: 3942969 - Cancer. 1986 Jan 15;57(2):362-7 – reference: 16835335 - Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54 – reference: 10228196 - N Engl J Med. 1999 May 6;340(18):1424-6 – reference: 16803653 - J Anal Toxicol. 2006 Apr;30(3):187-95 – reference: 3994914 - Br J Cancer. 1985 May;51(5):707-12 – reference: 17204516 - Am J Epidemiol. 2007 Mar 15;165(6):660-6 – reference: 9498898 - Cancer Causes Control. 1997 May;8(3):346-55 – reference: 17671226 - Cancer Res. 2007 Aug 1;67(15):7540-5 – reference: 11287448 - J Natl Cancer Inst. 2001 Apr 4;93(7):538-45 – reference: 6929006 - J Natl Cancer Inst. 1980 Apr;64(4):977-89 – reference: 14685762 - World J Urol. 2004 Feb;21(6):392-401 – reference: 12814994 - Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7 – reference: 10738259 - Int J Cancer. 2000 Apr 15;86(2):289-94 – reference: 12955743 - Rapid Commun Mass Spectrom. 2003;17(18):2125-32 – reference: 2793235 - Int J Cancer. 1989 Oct 15;44(4):622-8 – reference: 17510079 - Int J Epidemiol. 2007 Feb;36(1):236-41 – reference: 9245661 - Prev Med. 1997 Jul-Aug;26(4):427-34 – reference: 9241071 - Cancer. 1997 Aug 1;80(3):382-8 – reference: 10928863 - Mutat Res. 2000 Jul;463(1):103-10 – reference: 7827847 - Br J Urol. 1994 Dec;74(6):753-6 – reference: 19880815 - J Natl Cancer Inst. 2009 Nov 18;101(22):1532-4 |
SSID | ssj0000924 |
Score | 2.3713377 |
Snippet | Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total... Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total... Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref oup istex |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1553 |
SubjectTerms | Adult Aged Biological and medical sciences Bladder Cancer Case-Control Studies Cigarettes Female Humans Incidence Maine - epidemiology Male Medical research Medical sciences Middle Aged Nephrology. Urinary tract diseases New Hampshire - epidemiology Odds Ratio Oncology Risk Assessment Risk Factors Smoking Smoking - adverse effects Smoking - epidemiology Smoking Cessation Tumors Tumors of the urinary system Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - etiology Urinary tract. Prostate gland Vermont - epidemiology |
Title | A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time |
URI | https://api.istex.fr/ark:/67375/HXZ-S6J7PZXQ-7/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/19917915 https://www.proquest.com/docview/220987265 https://www.proquest.com/docview/734145890 https://www.proquest.com/docview/899130172 https://pubmed.ncbi.nlm.nih.gov/PMC2778671 |
Volume | 101 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhLiOMhh-mHhgCkvjW8tbVS5j0iYQHar2EjmOA-ySVk0rIcSP55zYSZqpQ8BLW8WuXeX7fHrsfOccQnY1ZyZFzZPSNgrAv82CRGUiYDYTWmZM6bIYzNGxPDjhhxMx6XR-rUaXLJJX5ufauJL_QRWuAa4YJfsPyNaDwgX4DPjCKyAMr3-F8XDPwJ9QUMnNiypBdHE5Pa-CD5MLtC1zVHcZeEMpeVmNx4VdLjCxKp4JFnuo5SxLzbf81ePRh_LUYMVxLWWR1RniyA1baw6ak9G5y17wBu7Csjbreq6_uhCyqsJuo1j8gkki3VOQkYbhmgf-voyXC8hB-VPrrGKAQXvevFpnX7kMA9hlipYB9scZjmkuTNnbU6xqtNbQuyRYZ7lBkNKzGXMp3VdAn12WqKO0Sw1cyOiVzNpV0w2yGcEmA836-0kjEApha-ojOmG2fZxr381UZpp13225M5u4Mn9UoZK3Z7qAdZa5AinrdjBXhbgrns34LrnjkaVDx697pGPz--TmkRddPCDjIV2lGS1pRqcZ9TSjQDPqaUYdzSjS7DWtSEYrklEkGUWSPSQn796ORweBL8YRGCHVIuj3jGTcKs36nMlUycwkVoRWKtiw8zBKOTfgrgrOUtgFRKanDbh-GU-4MWmaCvaIbOTT3D4mdJCFRiZ96C8kt4wlPXTabY9HSgiRqi55Wd3T2PhM9Vgw5SJ2igkWIxaxw6JLduvOM5egZX23FyU4dR89P0dNoxLxweQ0_iwP1cfTyacYJn8O6P15qJ0WsnXfqNzeSxhiu4I69taigMZw0FeRFF1C61Yw5fh8Tud2uixiBR4lF_1BeH2XPtCO4bFNl2w56jS_1DOyS1SLVHUHTCTfbsm_fysTykeYRFL1nlw75ja51Sznp2RjMV_aZ-CML5Kdcs38BuJc4sA |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case-control+study+of+smoking+and+bladder+cancer+risk%3A+emergent+patterns+over+time&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Baris%2C+Dalsu&rft.au=Karagas%2C+Margaret+R&rft.au=Verrill%2C+Castine&rft.au=Johnson%2C+Alison&rft.date=2009-11-18&rft.eissn=1460-2105&rft.volume=101&rft.issue=22&rft.spage=1553&rft_id=info:doi/10.1093%2Fjnci%2Fdjp361&rft_id=info%3Apmid%2F19917915&rft.externalDocID=19917915 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8874&client=summon |